Abeona Therapeutics Inc.

05/19/2022 | Press release | Distributed by Public on 05/19/2022 05:36

Abeona Therapeutics Granted Second 180-Day Period by Nasdaq to Regain Compliance with Minimum Bid Price Rule - Form 8-K